Voyager Therapeutics (VYGR) Cash from Investing Activities (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Voyager Therapeutics | 230.25 Mn | 88.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -82.92% |
| Dec 31, 2025 | 35.93% |
| Sep 30, 2025 | 1,704.86% |
| Jun 30, 2025 | -95.31% |
| Mar 31, 2025 | 251.46% |
| Dec 31, 2024 | -142.27% |
| Sep 30, 2024 | 279.04% |
| Jun 30, 2024 | 62.58% |
| Mar 31, 2024 | -458.01% |
| Dec 31, 2023 | 116.95% |
| Sep 30, 2023 | -541.87% |
| Jun 30, 2023 | -270.20% |
| Mar 31, 2023 | 3.01% |
| Dec 31, 2022 | -59.49% |
| Sep 30, 2022 | 196.10% |
| Jun 30, 2022 | -80.67% |
| Mar 31, 2022 | -266.00% |
| Dec 31, 2021 | -138.10% |
| Sep 30, 2021 | -36.00% |
| Jun 30, 2021 | -35.29% |
| Mar 31, 2021 | 260.93% |
| Dec 31, 2020 | -178.65% |
| Sep 30, 2020 | 1,588.36% |
| Jun 30, 2020 | -101.69% |
| Mar 31, 2020 | 311.88% |
| Dec 31, 2019 | 17.04% |
| Sep 30, 2019 | 882.89% |
| Jun 30, 2019 | 97.89% |
| Mar 31, 2019 | -577.33% |
| Dec 31, 2018 | 2,499.83% |
| Sep 30, 2018 | 97.99% |
| Jun 30, 2018 | -201.66% |
| Mar 31, 2018 | 197.17% |
| Dec 31, 2017 | -2,071.28% |
| Sep 30, 2017 | -107.18% |
| Jun 30, 2017 | 86.56% |
| Mar 31, 2017 | 250.54% |
| Dec 31, 2016 | -307.55% |
| Sep 30, 2016 | -84.54% |
| Jun 30, 2016 | 254.31% |
| Mar 31, 2016 | 112.12% |
| Dec 31, 2015 | -847.18% |
| Sep 30, 2015 | 87.56% |
| Jun 30, 2015 | -56,252.67% |
| Mar 31, 2015 | 85.13% |